Arbutus Biopharma (ABUS) Accounts Payables (2010 - 2026)
Arbutus Biopharma (ABUS) recorded Accounts Payables of $2.85 million in Q2 2026, down 36.8% from $4.51 million a year earlier and down 36.3% from the prior quarter.
Arbutus Biopharma (ABUS) Accounts Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Arbutus Biopharma reported Accounts Payables of $5.46 million, down 27.8% from FY2024.
- Annual Accounts Payables has declined for three straight years, with a five-year compound annual growth rate of -9.8% (FY2020 to FY2025).
- Across earlier years, Accounts Payables came in at $7.56 million in FY2024 (-26.4%), $10.27 million in FY2023 (-35.9%), $16.03 million in FY2022 (+47.9%) and $10.84 million in FY2021 (+18.4%).
- The Q2 2026 figure is the lowest quarterly Accounts Payables in data going back to Q4 2010.
- On a year-over-year basis, Accounts Payables has declined for five consecutive quarters, with an average decline of 28.5% over the last eight quarters.
- Peak year-over-year performance for Accounts Payables in the last five years was growth of 49.4% in Q2 2022, against a decline of 63.1% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.47 million (Q1 2026), $5.46 million (Q4 2025) and $4.65 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Arbutus Biopharma | 841.23 Mn | 468.20 Mn | - | 2.85 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.85 Mn |
| Mar 31, 2026 | 4.47 Mn |
| Dec 31, 2025 | 5.46 Mn |
| Sep 30, 2025 | 4.65 Mn |
| Jun 30, 2025 | 4.51 Mn |
| Mar 31, 2025 | 12.11 Mn |
| Dec 31, 2024 | 7.56 Mn |
| Sep 30, 2024 | 7.54 Mn |
| Jun 30, 2024 | 11.11 Mn |
| Mar 31, 2024 | 8.25 Mn |
| Dec 31, 2023 | 10.27 Mn |
| Sep 30, 2023 | 9.81 Mn |
| Jun 30, 2023 | 8.81 Mn |
| Mar 31, 2023 | 9.65 Mn |
| Dec 31, 2022 | 16.03 Mn |
| Sep 30, 2022 | 12.27 Mn |
| Jun 30, 2022 | 12.47 Mn |
| Mar 31, 2022 | 8.72 Mn |
| Dec 31, 2021 | 10.84 Mn |
| Sep 30, 2021 | 9.73 Mn |
Arbutus Biopharma Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=ABUS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();